The IPO13 gene gives cells instructions for a transport protein that moves selected proteins into and out of the nucleus, the cell’s control center. In medicine, this gene is important because it helps regulate signals needed for normal cell function and early development. If the IPO13 gene does not work properly, these signals may be misplaced, which can disrupt how tissues grow and mature. Rare harmful variants in both copies of the IPO13 gene have been linked to inherited developmental conditions, sometimes affecting the skeleton and other organs.
What is a gene?
A gene is a section of DNA that gives your cells instructions they can use to make molecules or regulate processes in the body. Some genes carry the information needed to make proteins, the parts of cells that do the work. Other genes are mainly involved in controlling when certain processes happen, where they take place, and how strongly they occur. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. If you want to look into this topic more deeply, you can read more in the LearnHub.
Overview
IPO13Gene function
What if the gene works
The IPO13 gene helps move certain proteins between the cell’s outer area and its control center, the nucleus. This transport supports normal gene activity, cell growth, and early development.
Risk
What if the gene does not work
Changes in the IPO13 gene can weaken the movement of certain proteins into and out of the nucleus, the cell’s control center. Milder variants may partly reduce this transport, while more severe variants can disrupt it more.
Treatment
What does that mean for your treatment
For a pathogenic or loss-of-function variant in the IPO13 gene, no gene-specific treatment or drug choice is currently established in clinical guidelines. The IPO13 gene is being studied as a possible marker of treatment response, including steroid response, but this has not yet changed routine care.
Gene function
What if the gene works
Your cells constantly send important proteins to the nucleus, where genetic instructions are used, and back again. The IPO13 gene helps manage this movement so the right proteins are in the right place. That steady traffic supports everyday cell function.
The IPO13 gene helps move selected proteins from the main part of the cell into the nucleus. This allows control proteins to reach DNA and help guide which genes the cell uses.
The protein made from the IPO13 gene can also carry some proteins out of the nucleus. This return trip helps keep protein traffic balanced and cell activity well organized.
By placing regulatory proteins in the right compartment, the IPO13 gene supports steady gene activity and routine cell tasks. This is a key part of how the IPO13 gene works in the body.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to, or in some cases cause, a genetic condition.
Genetic variants
What if the gene does not work
At the cell level, how IPO13 gene variants affect protein function depends on the change itself: some weaken cargo binding or nuclear transport, while others destabilize or shorten the protein. Milder variants may leave partial activity, while more disruptive variants can lead to little or no transport of partner proteins between the cell and nucleus. These changes can also alter protein interactions and where key signaling proteins end up inside the cell.
How variants are linked to conditions
At present, the IPO13 gene does not yet have a broadly confirmed link to a specific health condition, although research on how IPO13 gene variants are linked to conditions is still developing. If you have a confirmed change in the IPO13 gene, your doctor or genetic counselor can explain what that result means for you in the context of your personal and family history.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not directly affect health and simply contribute to natural human variation. For many genes, having a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, one well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the IPO13 gene. If a change in IPO13 is found on genetic testing, a doctor or genetic counselor can explain what it may mean for personal and family risk.
Inheritance of IPO13 variants
There is not yet a broadly confirmed, disease-specific IPO13 inheritance pattern used in routine human genetics, so how IPO13 variants are inherited is not tied to one well-established dominant, recessive, or X-linked condition at this time. The IPO13 gene is located on chromosome 1, which is an autosome. That means each person inherits two copies of the IPO13 gene, one from each parent.
What does my IPO13 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific, well-established condition for IPO13, though this can become clearer as research grows. If you have a specific IPO13 result, a doctor or genetic counselor can explain what it may mean for close relatives based on the exact change that was found.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for IPO13 gene variants uses blood, saliva, or a cheek swab. A lab reads the DNA code of the IPO13 gene, often in a gene panel or exome test, and classifies any change as benign, uncertain, or pathogenic.
When should I consider getting a genetic test?
There isn't yet a broadly established, IPO13-specific clinical reason for testing in routine care. Decisions about genetic testing are usually based on your symptoms, personal health history, and family history, and are best made with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide valuable information, but how much it explains varies based on the condition and the specific type of variant. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most useful when considered with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, these results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down or move a drug through the body differently, so the same treatment may work better for one person, seem weaker for another, or cause more side effects. This kind of difference is common and is one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics focuses on how differences in genes can shape a person’s response to medicines. It examines the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medications, genes can influence how the body handles a drug or how strong its effects are. This understanding can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the IPO13 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, new symptoms, or how well a treatment is working are best discussed with your doctor.
History
The IPO13 gene entered the scientific literature in the early 2000s, during a period when researchers were mapping many genes involved in moving proteins within cells. Initially understood only through visible traits, later recognized as tied to a specific gene, this area of research helped place the IPO13 gene within the larger importin family. Building on this early work, scientists compared IPO13 across species and found that it had been preserved through evolution, which increased interest in its biological importance. As laboratory methods improved, studies described where the IPO13 gene is active in the body and how its activity changes in different tissues. Over time, descriptions became more precise, and the IPO13 gene became part of broader research on cell transport, development, and inherited health conditions.